search
Back to results

Assessing the Impact of Group Antenatal Care on IPTp Uptake in Tanzania (GANC-TZ)

Primary Purpose

Malaria, Malaria in Pregnancy

Status
Terminated
Phase
Not Applicable
Locations
Tanzania
Study Type
Interventional
Intervention
Group antenatal care (GANC)
Standard antenatal care
Sponsored by
Centers for Disease Control and Prevention
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Malaria focused on measuring Group antenatal care, Surveillance, Tanzania, Malaria in Pregnancy

Eligibility Criteria

15 Years - 45 Years (Child, Adult)FemaleDoes not accept healthy volunteers

Pregnant women for GANC and ANC surveillance:

Inclusion Criteria

  • Pregnant women residing in the facility catchment area, who present for initial ANC visit prior to 24 weeks are eligible to participate in GANC provided that they intend to remain in the area for the duration of the pregnancy, and agree to participate in GANC. All women attending first ANC at participating facilities will be asked to respond to a short list of questions regarding the coverage of malaria control interventions in their household.

Exclusion criteria

• Pregnant women: Women will be excluded from participation in GANC if they initiate ANC care >24 weeks gestation, if there are no available groups that they can join, if they do not intend to remain in the facility catchment area for the duration of the study, or if they are not available during the times the group intends to meet. Women will also be excluded if they do not speak Swahili, as group discussions will be conducted in Swahili.

Recently pregnant women (for cross sectional household surveys) Inclusion Criteria • To be included in the women's question portion of the baseline and end line household (HH) surveys, women must be between the ages of 15-49 years, have been pregnant/delivered in the previous 12 months, consent to participation, and will be eligible for inclusion in surveys regardless of where the woman gave birth (i.e., whether at home or in facility). All pregnant/recently pregnant women will be included in the cross sectional survey, but the sample size is calculated in order to identify those who have completed pregnancies in the past 12 months. There will be a short subset of demographic and knowledge questions which will be asked of all households (either female or male respondents) during the baseline and end line surveys, regardless of whether there are any recently pregnant women in the household.

Exclusion criteria • Women who gave birth in the past 12 months, but are <15 or >49 years will be excluded. Those who last delivered a child over twelve months ago will be excluded from survey questions specific to recently pregnant women, but may answer questions related to community perception or general demographics. For qualitative research, the same criteria will be used.

Children (for blood sampling during the cross sectional household surveys) Inclusion Criteria

• Children between the ages of 6-59 months will be included provided that they are living in households interviewed during the baseline or end line cross sectional survey and a parent or legal guardian provides consent for their participation

Exclusion criteria • Children will be excluded if they are <6 months or >59 months, or if their parent/guardian is not present or does not provide consent

Providers:

Inclusion Criteria

  • ANC provider who has had at least six months of work experience
  • Health facility in-charge
  • Health management information system (HMIS) focal person

Exclusion criteria

• Those who have been working in the health facility for less than six months will not be interviewed due to low levels of relevant experience or exposure to the intervention.

Policy makers:

Inclusion Criteria

• In depth interviews may be conducted with program managers (malaria, reproductive health, and statistics/ data collection officers) at the district, regional and national levels

Exclusion criteria

• None

Sites / Locations

  • Chato District Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Group ANC Intervention

Routine ANC

Arm Description

Clinics in the group ANC intervention arm offer group Antenatal Care to women who present for their initial visit prior to 24 weeks provided that they intend to remain in the area for the duration of the pregnancy, and agree to participate in GANC. Women not enrolled in group ANC will receive standard ANC per ministry of health protocols.

Clinics will offer only standard ANC per ministry of health protocols.

Outcomes

Primary Outcome Measures

Change in proportion of recently pregnant women receiving IPTp3
Proportion of recently pregnant women receiving IPTp3 as measured by cross sectional household surveys
Correlation between ANC data and population data
Correlation between ANC data and population data collected during cross sectional survey on ITN ownership and care seeking behavior among children

Secondary Outcome Measures

Change in ANC coverage
Proportion of recently pregnant women completing the four, six, and eight ANC visits as measured by cross sectional household survey
Change in Gestational age at initiation of ANC
Mean gestational age at initiation of ANC measured by cross sectional household survey
Change in Proportion of women who recently gave birth who received blood pressure, urine test, blood test, tetanus, IFA, albendazole, ITN, and IPTp
Change in Proportion of women who recently gave birth who received blood pressure, urine test, blood test, tetanus, IFA, albendazole, ITN, and IPTp as measured by cross sectional household surveys
Change in Proportion of women who recently gave birth who had a facility-based delivery as measured by cross sectional household surveys
Prevalence of malaria by RDT among pregnant women attending 1st ANC
Prevalence of malaria by RDT among among children under 5
Difference in provider time required to deliver GANC versus individual ANC

Full Information

First Posted
October 25, 2019
Last Updated
July 22, 2021
Sponsor
Centers for Disease Control and Prevention
Collaborators
Jhpiego, Ministry of Health, Tanzania
search

1. Study Identification

Unique Protocol Identification Number
NCT04148690
Brief Title
Assessing the Impact of Group Antenatal Care on IPTp Uptake in Tanzania
Acronym
GANC-TZ
Official Title
Assessing the Impact of IPTp Uptake Among Pregnant Women Attending Antenatal Clinic and Feasibility of Malaria Surveillance to Community Based Surveillance in Tanzania
Study Type
Interventional

2. Study Status

Record Verification Date
July 2021
Overall Recruitment Status
Terminated
Why Stopped
Group intervention suspended due to COVID-19 risk
Study Start Date
November 15, 2019 (Actual)
Primary Completion Date
July 10, 2021 (Actual)
Study Completion Date
July 10, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Centers for Disease Control and Prevention
Collaborators
Jhpiego, Ministry of Health, Tanzania

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Group antenatal care (GANC) is a service delivery model where women with pregnancies of similar gestational age are brought together for antenatal care (ANC), incorporating information sharing and peer support. This model provides selected aspects of clinical care to women in the group at the same time during group visits, as well as creating a support group of women at a similar stage in pregnancy, to improve the quality of care and engagement of women in the ANC process, ultimately leading to better retention in care. Initial studies have suggested that this improves uptake of intermittent preventive treatment in pregnancy (IPTp) among women who participate, but have not evaluated the effect at community level. The investigators propose to assess whether use of the GANC model in Tanzania can improve the quality of ANC as compared to standard individual ANC, by measuring uptake of recommended interventions, primarily IPTp. Recent data from Tanzania and Kenya suggest that malaria parasitemia prevalence among pregnant women correlates with the prevalence among children under five, and could be used to track trends over time.3-5 The very high coverage of ANC (>80% attending at least one ANC contact), suggests that pregnant women could be a good sentinel population that could be readily tracked over time. However, pregnant women represent only about 5% of the overall population, thus, it is important to demonstrate that the trends in malaria prevalence and household level coverage of interventions reported by pregnant women attending ANC is representative of coverage among the general population. If validated, these data could be used to augment or even replace the data on coverage of interventions collected through the use of malaria indicator surveys, which are expensive and infrequently conducted, and generally only powered to the regional level.
Detailed Description
Project Background Group antenatal care (GANC) is a service delivery model where women with pregnancies of similar gestational age are brought together for antenatal care (ANC), incorporating information sharing and peer support. This model provides selected aspects of clinical care to women in the group at the same time during group visits, as well as creating a support group of women at a similar stage in pregnancy, to improve the quality of care and engagement of women in the ANC process, ultimately leading to better retention in care. Initial studies have suggested that this improves uptake of intermittent preventive treatment in pregnancy (IPTp) among women who participate, but have not evaluated the effect at community level. The investigators propose to assess whether use of the GANC model in Tanzania can improve the quality of ANC as compared to standard individual ANC, by measuring uptake of recommended interventions, primarily IPTp. Tanzania have been selected as coverage of early ANC is high, with 98% of women receiving ANC from a trained provider in Tanzania and 83% in Benin,1 with a median age of initiation of five and four months, respectively. Coverage of 4 ANC visits, however, is sub-optimal: just 36% in Geita region of Tanzania. Despite the relatively early initiation of ANC, in Tanzania only 56% and 26% of women received two and three doses of IPTp. Recent data from Tanzania and Kenya suggest that malaria parasitemia prevalence among pregnant women correlates with the prevalence among children under five, and could be used to track trends over time.3-5 The very high coverage of ANC (>80% attending at least one ANC contact), suggests that pregnant women could be a good sentinel population that could be readily tracked over time. However, pregnant women represent only about 5% of the overall population, thus, it is important to demonstrate that the trends in malaria prevalence and household level coverage of interventions reported by pregnant women attending ANC is representative of coverage among the general population. If validated, these data could be used to augment or even replace the data on coverage of interventions collected through the use of malaria indicator surveys, which are expensive and infrequently conducted, and generally only powered to the regional level. Study Aims Primary Objectives: GANC: Assess whether GANC is associated with to improved uptake of IPTp; specifically, to assess whether the proportion of pregnant women receiving 3 or more doses of IPTp is higher in the catchment areas of facilities implementing the GANC intervention as compared to the catchment areas of control facilities without GANC. ANC data for surveillance: Pilot data collection from women at 1st ANC and validate whether the results obtained from this population are representative of the population as a whole. Secondary Objectives: GANC To assess whether implementation of GANC is associated with to a greater proportion of women completing the recommended number of ANC visits compared to control facilities without GANC. To assess whether the implementation of GANC leads to earlier initiation of ANC compared to control facilities without GANC, as women can only participate in GANC if they present <24 weeks. To assess whether GANC is associated with increased utilization of facility-based delivery To assess whether GANC is associated with improved quality of care (defined as the coverage of key ANC interventions- blood pressure, urine test, blood test, tetanus, iron-folic acid (IFA), albendazole, insecticide treated bednet (ITN), IPTp) To assess the feasibility and acceptability of increasing the coverage of GANC To assess the costs and cost effectiveness of GANC versus individual ANC (standard of care) ANC data for Surveillance To understand the acceptability to pregnant women and healthcare workers of being asked/asking these additional questions during ANC contacts. To quantify the time per woman required to collect data on coverage of malaria control interventions into ANC To assess the correlation between the prevalence of malaria by rapid diagnostic test (RDT) among pregnant women attending 1st ANC and among children under 5 measured in cross sectional household surveys To explore optimal data collection strategies and determine how best to operationalize them (i.e., should data be collected and recorded by ANC providers or another cadre; e.g., a community health worker stationed at the clinic). Methodology Study design: This will be a cluster randomized controlled trial conducted over an 18-month period. Facilities will be randomized 1:1 to control and intervention arms. In the control arm, ANC care will be delivered as per standard practice. In the intervention sites, women presenting for first ANC prior to 24 weeks will be offered the opportunity to join group care (as long as there is still space in an appropriate group) starting with the 2nd visit; women presenting after 24 weeks or declining to join a group will receive standard ANC care. Baseline and end line cross sectional household surveys will be conducted 18 months apart to measure the proportion of women living in the facility catchment areas who have completed a pregnancy (ie. given birth) within the past 12 months in each community who received 1, 2, 3, 4, and 5+ doses of IPTp, the timing of initiation of ANC, number of total ANC visits, facility-based delivery, birth outcomes, as well as validate the representativeness of data on parasite prevalence, insecticide treated net (ITN) ownership and use, and care seeking. The sample size in each country will be sufficient to allow for an estimate of the effect of GANC for each country, as the effectiveness of this model is dependent on the proportion of women who attend ANC early, which is somewhat higher in Benin than in Tanzania. Implications The results will be used by the Ministries of Health (MOH) in Tanzania to decide: whether to expand the use of GANC as a strategy to improve quality of care and increase utilization of ANC; and whether pregnant women attending first ANC can be used as a sentinel population to improve surveillance of malaria control interventions. Expected findings and dissemination The investigators will share the results of this study with the MoHs and the partners working in malaria and maternal and child health through: country-based technical working groups in malaria and maternal and newborn health; community leaders; and women's associations-as well as dissemination events and print materials. The findings will contribute to the evidence to determine whether GANC is associated with improved ANC attendance, IPTp uptake, and quality of care (as defined as the delivery of specific interventions), and whether it should be scaled-up in other suitable malaria endemic regions. The findings on ANC surveillance will contribute to the evidence about whether this method of surveillance is effective and should be scaled up. The results will also be presented in both local and international scientific meetings and published in a peer-reviewed journal.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Malaria, Malaria in Pregnancy
Keywords
Group antenatal care, Surveillance, Tanzania, Malaria in Pregnancy

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
This will be a cluster randomized controlled trial conducted over an 18-month period. Facilities will be randomized 1:1 to control and intervention arms.
Masking
Outcomes Assessor
Masking Description
the outcomes will be assessed through conduct of a cross sectional survey; those conducting the survey will not be informed as to which arm the women were in
Allocation
Randomized
Enrollment
4515 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Group ANC Intervention
Arm Type
Experimental
Arm Description
Clinics in the group ANC intervention arm offer group Antenatal Care to women who present for their initial visit prior to 24 weeks provided that they intend to remain in the area for the duration of the pregnancy, and agree to participate in GANC. Women not enrolled in group ANC will receive standard ANC per ministry of health protocols.
Arm Title
Routine ANC
Arm Type
Active Comparator
Arm Description
Clinics will offer only standard ANC per ministry of health protocols.
Intervention Type
Other
Intervention Name(s)
Group antenatal care (GANC)
Intervention Description
Group antenatal care (GANC) is a service delivery model where women with pregnancies of similar gestational age are brought together for antenatal care (ANC), incorporating information sharing and peer support.
Intervention Type
Other
Intervention Name(s)
Standard antenatal care
Intervention Description
Routine antenatal care as recommended by th Ministry of Health of Tanzania
Primary Outcome Measure Information:
Title
Change in proportion of recently pregnant women receiving IPTp3
Description
Proportion of recently pregnant women receiving IPTp3 as measured by cross sectional household surveys
Time Frame
Change between 0 and 18 months of implementation
Title
Correlation between ANC data and population data
Description
Correlation between ANC data and population data collected during cross sectional survey on ITN ownership and care seeking behavior among children
Time Frame
Through study completion, an average of 1 year
Secondary Outcome Measure Information:
Title
Change in ANC coverage
Description
Proportion of recently pregnant women completing the four, six, and eight ANC visits as measured by cross sectional household survey
Time Frame
Change between 0 and 18 months of implementation
Title
Change in Gestational age at initiation of ANC
Description
Mean gestational age at initiation of ANC measured by cross sectional household survey
Time Frame
Change between 0 and 18 months of implementation
Title
Change in Proportion of women who recently gave birth who received blood pressure, urine test, blood test, tetanus, IFA, albendazole, ITN, and IPTp
Description
Change in Proportion of women who recently gave birth who received blood pressure, urine test, blood test, tetanus, IFA, albendazole, ITN, and IPTp as measured by cross sectional household surveys
Time Frame
Change between 0 and 18 months of implementation
Title
Change in Proportion of women who recently gave birth who had a facility-based delivery as measured by cross sectional household surveys
Time Frame
Change between 0 and 18 months of implementation
Title
Prevalence of malaria by RDT among pregnant women attending 1st ANC
Time Frame
throughout study period; average of once per month
Title
Prevalence of malaria by RDT among among children under 5
Time Frame
throughout study period; average of once per year
Title
Difference in provider time required to deliver GANC versus individual ANC
Time Frame
12 months

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
15 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Pregnant women for GANC and ANC surveillance: Inclusion Criteria Pregnant women residing in the facility catchment area, who present for initial ANC visit prior to 24 weeks are eligible to participate in GANC provided that they intend to remain in the area for the duration of the pregnancy, and agree to participate in GANC. All women attending first ANC at participating facilities will be asked to respond to a short list of questions regarding the coverage of malaria control interventions in their household. Exclusion criteria • Pregnant women: Women will be excluded from participation in GANC if they initiate ANC care >24 weeks gestation, if there are no available groups that they can join, if they do not intend to remain in the facility catchment area for the duration of the study, or if they are not available during the times the group intends to meet. Women will also be excluded if they do not speak Swahili, as group discussions will be conducted in Swahili. Recently pregnant women (for cross sectional household surveys) Inclusion Criteria • To be included in the women's question portion of the baseline and end line household (HH) surveys, women must be between the ages of 15-49 years, have been pregnant/delivered in the previous 12 months, consent to participation, and will be eligible for inclusion in surveys regardless of where the woman gave birth (i.e., whether at home or in facility). All pregnant/recently pregnant women will be included in the cross sectional survey, but the sample size is calculated in order to identify those who have completed pregnancies in the past 12 months. There will be a short subset of demographic and knowledge questions which will be asked of all households (either female or male respondents) during the baseline and end line surveys, regardless of whether there are any recently pregnant women in the household. Exclusion criteria • Women who gave birth in the past 12 months, but are <15 or >49 years will be excluded. Those who last delivered a child over twelve months ago will be excluded from survey questions specific to recently pregnant women, but may answer questions related to community perception or general demographics. For qualitative research, the same criteria will be used. Children (for blood sampling during the cross sectional household surveys) Inclusion Criteria • Children between the ages of 6-59 months will be included provided that they are living in households interviewed during the baseline or end line cross sectional survey and a parent or legal guardian provides consent for their participation Exclusion criteria • Children will be excluded if they are <6 months or >59 months, or if their parent/guardian is not present or does not provide consent Providers: Inclusion Criteria ANC provider who has had at least six months of work experience Health facility in-charge Health management information system (HMIS) focal person Exclusion criteria • Those who have been working in the health facility for less than six months will not be interviewed due to low levels of relevant experience or exposure to the intervention. Policy makers: Inclusion Criteria • In depth interviews may be conducted with program managers (malaria, reproductive health, and statistics/ data collection officers) at the district, regional and national levels Exclusion criteria • None
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ruth Lemwayi, MD
Organizational Affiliation
Jhpiego
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Julie R Gutman, MD MSc
Organizational Affiliation
Centers for Disease Control and Prevention
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Mary Drake
Organizational Affiliation
Jhpiego
Official's Role
Principal Investigator
Facility Information:
Facility Name
Chato District Hospital
City
Chato
Country
Tanzania

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
Individual participant data may only be made available upon specific request after appropriate approvals for data sharing have been granted by Tanzanian authorities

Learn more about this trial

Assessing the Impact of Group Antenatal Care on IPTp Uptake in Tanzania

We'll reach out to this number within 24 hrs